Ganitumab
Ganitumab (AMG 479) is a highly potent monoclonal antibody targeting the type 1 insulin-like growth factor receptor (IGF1R) . Recognized for binding IGF1R at low concentrations with a KD value of 0.22 nM, Ganitumab inhibits IGF1R interactions with IGF1 and IGF2 in mice, making it useful for cancer research.
Product Specifications
CAS Number
905703-97-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IGF-1R
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS952333-01 0.02 mg (E-Coli)
Recombinant Human Desmoglein-3 (DSG3), partial
Sign In for Pricing
View Details MBS952333-02 0.02 mg (Yeast)
Recombinant Human Desmoglein-3 (DSG3), partial
Sign In for Pricing
View Details MBS952333-03 0.1 mg (E-Coli)
Recombinant Human Desmoglein-3 (DSG3), partial
Sign In for Pricing
View Details